Szentendre, Hungary

Sandor Istvan

This inventor holds 4 USPTO granted patents. Top assignee: Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.. Active years: 1982-1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sandor Istvan. Retrieved from https://idiyas.com/inventor/sandor-istvan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1982-1983

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Sandor Istvan: Innovator in Microbial Production

Introduction

Sandor Istvan is a notable inventor based in Szentendre, Hungary. He has made significant contributions to the field of microbiology, particularly in the production of antibiotics. With a total of four patents to his name, Istvan's work has had a meaningful impact on pharmaceutical development.

Latest Patents

Among his latest patents is the discovery of a new species, Micromonospora danubiensis, which has the capability of producing sisomicin. Additionally, he has developed a method for the production of sisomicin through the culturing of Micromonospora danubiensis. These innovations highlight his expertise in microbial culture and antibiotic production.

Career Highlights

Sandor Istvan is currently associated with Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., a prominent pharmaceutical company. His work there has focused on advancing microbial production techniques, contributing to the development of new antibiotics.

Collaborations

Istvan has collaborated with notable colleagues, including Istvan Gado and Miklos Jarai. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

Sandor Istvan's contributions to microbiology and antibiotic production are commendable. His innovative patents and collaborations reflect his dedication to advancing pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…